Mayne Pharma Group Ltd
ASX:MYX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mayne Pharma Group Ltd
ASX:MYX
|
AU |
|
S
|
SPSoft Inc
KOSDAQ:443670
|
KR |
|
Newlat Food SpA
MIL:NWL
|
IT |
|
M
|
MiTAC Holdings Corp
TWSE:3706
|
TW |
|
Y
|
YPF SA
BCBA:YPFD
|
AR |
|
Brisbane Broncos Ltd
ASX:BBL
|
AU |
|
Xtract One Technologies Inc.
TSX:XTRA
|
CA |
|
E
|
Emerson Electric Co
BMV:EMR
|
US |
|
Ryanair Holdings PLC
NASDAQ:RYAAY
|
IE |
Wall Street
Price Targets
MYX Price Targets Summary
Mayne Pharma Group Ltd
According to Wall Street analysts, the average 1-year price target for
MYX
is 6.22 AUD
with a low forecast of 6.16 AUD and a high forecast of 6.41 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MYX's stock price target?
Price Target
6.22
AUD
According to Wall Street analysts, the average 1-year price target for
MYX
is 6.22 AUD
with a low forecast of 6.16 AUD and a high forecast of 6.41 AUD.
What is Mayne Pharma Group Ltd's Revenue forecast?
Projected CAGR
13%
For the last 7 years the
compound annual growth rate for
Mayne Pharma Group Ltd's revenue is
-4%.
The projected
CAGR
for the next 2 years is
13%.
